Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed... see more

TSX:PRN - Post Discussion

Profound Medical Corp > Dr Arun recently had TULSA
View:
Post by Charlie263 on Jun 23, 2021 1:00am

Dr Arun recently had TULSA

Dr Arun recently had TULSA in June, and gave the live testimonial on success of TULSA at Raymond James conference! Thanks to him for the same.
Comment by MrMugsy on Jun 30, 2021 9:40am
Funny Charlie ... just saw that for the first time yesterday. I didn't realize he was being emotional ... thought he was sick and coughing. Then I realized he was holding back tears. Gotta admit ... that was a little strange ... but having a CEO who just lived it gives TULSA a personal side. 
Comment by Charlie263 on Jul 02, 2021 11:39am
The case for TULSA is promising. It's target patient base in just US is 500k approx. Assuming it just tap in 25% of market i.e. 125,000 patients per year by 2025...that will bring this company to approx. USD 1 Billion plus annual revenue just in US. from TULSA.  It's a matter of time, patience and vision...if all goes well ...PROF is going to fly high...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities